• Abdel-Rahman, Fawzia- Professor
• Dumond, James- Assistant Professor
• Fadulu, Sunday O. - Professor
• Ghosh, Debabrata - Professor
• Hillar, Marion- Professor
• Hogan, Yvonne H. - Professor
• Jackson, Desirée - Assistant Professor
• Jejelowo, O.A. -  Professor
• Miranda, Hector C. - Assistant Professor
• Ramesh, Govindarajan - Assistant Professor
• Shishodia, Shishir - Assistant Professor
• Sundaresan, Alamelu - Assistant Professor
• Williams, Warren E - Associate Professor

Fadulu, Sunday O. - Professor

List Research Interest Keywords:

Medical Microbiology – emphasis on Medical Mycology, Sickle Cell Anemia – Clinical Trial of Hemogenol – A drug to cure Sickle Cell Anemia/Thalassemia

Review Panels:

• National Science Foundation (NSF) Review Panel
• National Review Committee for NSF Research Funding
• Ronald McNair Research Program
• National Review Program

Training/Instructional Capability:

• Training in Biology/Chemistry generally specifically – Microbiology and Biochemistry with special emphasis on Pathology, Hematology, Mycology, Immunology, Clinical Microbiology and Sickle Cell Anemia

Selected Publications:

1. Fadulu, S.O.  NX06999 Stimulates Increased Fetal Hemoglobin Expression in Bone Marrow Culture Established Under Gravity and Microgravity Conditions.  (1999).  “Microgravity and Sickle Cell Anemia.”  NASA #NAG 9-862.
2. Fadulu, S.O.  F-Cell Count Increases With the Administration of an Anti-Hemoglobinopathic Agent Under Gravity and Microgravity Conditions in Adult Normal Bone Marrow (1999) National Medical Association Journal.
3. Fadulu, S.O. and Jackson, D.A.  Hemogenol (NX06999) (2002).  Hemogene Pharmaceutical Company Inc., Houston, Texas.

Recent Proposals Written:

• Clinical Determination of the Safety of Hemogenol (code-name) NX06999 and Iti pharmacokinetics.  NIH-National Institute of 2002.

Recent Professional Conferences Attended:

• National Medical Association Conference 2002

Recent Training Workshops Attended: (TSU or External)

• Workshop and Training for Reporation of the Proposed Clinical Test for the Sickle Cell Drug.  Riverside General Hospital is center to co-ordinate the National Trials and Texas Southern University will co-ordinate the non-clinical laboratory tests on specimens from the hospital during the trial.

List of Professional Activities:

• Environmental Toxicity Program – Doctoral Program
• Comprehensive Examination Committee member
• Graduate Faculty Member and Advisory Committee Member for the Master’s Degree Program

List of Community and University Services:

• Member:   Board of Trustees, Riverside General Hospital
• Member:  Departmental Committee – Rank and Tenure for the Department of Biolog
• Upward Bound Program – Member of the High School Scientific Research Exhibition and Competition Committee.
• Convocation Speaker at Oklahoma Baptist University and the award presentation of honorary Doctor of Science degree for the research on sickle cell anemia (2000).

Awards and Special Recognitions:

Hogan, Yvonne H. - Professor

List Research Interest Keywords:

Nueroscience, pharmacology, adenosine receptors, parasitology, Trypanosoma

Review Panels:

• Panelist National Science Foundation, 1987-2003
• Chair of NSF Panel, 2003 –Animal and Plant Sciences
• Panelist NIGMS Bridges Program
• Reviewer MARC Program, Florida A&M

Training/Instructional Capability:

Hypertension Research, Neurosciences, Parasitology / Immunology, Developmental Biology, General Biology, Anatomy and Physiology, Microbiology, Laboratory Methods in Animal Biology, Cytology.

Selected Publications:

• Alkadhi, Karim A et. al.  Inhibition of Ganglionic Long-Term Potentiation decreases blood pressure in spontaneously Hypertensive Rats.  Experimental Biology & Medicine,2001.
• Hogan, Y.H. et al.  Adenosine-induced blockade of sympathetic ganglia: Antagonism by cyclic AMP.  Journal of Aut. Nerv. Syst., 1995.
• Alkadhi, Karim et. al.  Retrograde Carbon Monoxide is Required for Induction of Long-Term Potentiation in Rat Superior Cervical Ganglion.  Journal of Neuroscience, 21 (10): 3515-3520; 2001.

Recent Proposals Written:

Recent Professional Conferences Attended:

• Texas Association of Advisors of Health Professions, Austin, TX, February 2003.
• EMSAP Conference, Padre Island, TX, September 2002.
• JAMP Conference, Austin, TX, September 2002.

Recent Training Workshops Attended: (TSU or External)

• Globe Trainee Workshop, Washington D.C., March 2002.

List of Professional Activities:

• Beta Beta Beta Honor Society –Sponsor

List of Community and University Services:

• TMO, The Metropolitan Organization, Former Co-Chair

Awards and Special Recognitions:

Jackson, Desirée - Assistant Professor & Chair                                                                          

Email: jackson_da@tsu.edu
Office Phone: 713 313-7778
Highest Degree Obtained: Ph.D.
Year: 1992
School: Meharry Medical College

List Research Interest Keywords:

Sickle cell anemia, Hemoglobin, Hemoglobin F, b-thalassemia, Molecular biology, Molecular genetics, Biotechnology, Microgravity, Mutation analysis, Gene sequencing, Toxicogenomics, Arsenic, Differential Gene Expression

Review Panels:

• Panel for the NIH Consensus Development Conference on Screening and Management for      Phenylketonuria (PKU)
• Laboratory Manual, Biology 6e, by Vodopich and Moore, McGraw-Hill Publishers
• Texas Science Explorer Grade 8, Prentice Hall Publishers

Training/Instructional Capability:

• Non-majors: Survey of Life Sciences. Biology majors: Biological Sciences I, Biological Sciences II, Cell Biology, Developmental Biology, Experiments in Biology I, Experiments in Biology II, Undergraduate Research, Laboratory Methods in the Biological Sciences, Molecular Biology.

• Graduate level: Experimental Biology

Selected Publications:

1. DNA Diagnosis Confirms Hemoglobin Deletion in Newborn Screen Follow-up. Bhardwaj, U., Zhang, Y-H., Jackson, D. S., Buchanan, G.R., Therrell, B.L., McCabe, L.L., and McCabe, E.R.B. Submitted to the Journal of Pediatrics. (In Press)
2. Phenylketonuria (PKU): Screening and Management. NIH Consensus Statement 2000 October 16-18; 17(3): 1-33.
3. Report of the NIH Consensus Development Conference on Phenylketonuria: Screening and Management, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Child Health and Human Development, January 2001.
4. Unbiased analysis of beta-thalassemia point mutations in a population of African American newborns. Arch. Path. Lab. Med. 117:1110-1114 (1993).
5. Genomic scanning for expressed sequences in Xp21 identifies the glycerol kinase gene. Nature Genet. 4:367-372 (1993).
6. Characterization of a novel developmentally regulated gene from Trypanosoma brucei encoding a potential phosphoprotein. Mol. Biochem. Parasitol. 47:119-128. (1991).
7. A Comparison of the amino acid sequences of Crithidia fasciculata and Trypanosoma rhodesiense cytochromes c. J. Parasitol. 76:445-447 (1990)

Externally Funded Projects: (Title of Project and Funding Agency)

Recent Proposals Written:

TSU Seed Grant Proposal:

1. Principal Investigator, The Effect of Arsenic on Gene Expression: Evaluation of Pre-Natal Exposures and the Role of Genetic Variability. October, 2002
2. Contributor, NSF STEP Grant-Texas Southern University College of Science and Technology Enhancement Program
3. Co-Investigator, Clinical Determination of Safety of NX06999 and Pharmokinetics of NX06999. Sept 1, 1998

Recent Professional Conferences Attended:

• Society of Toxicology-March 2002
• Texas Association for Advisors to the Health Professions-2003

Recent Training Workshops Attended: (TSU or External)

List of Professional Activities:

• Panel Committee Member, Consensus Development Conference on Screening and Management for Phenylketonuria (PKU)

List of Community and University Services:

Current:

1. Retention Committee for the College of Science and Technology
2. Co-Chair, College of Arts and Sciences Student Development and Student Organizations Committee
3. College of Arts and Sciences Computerization and Instructional Technology Committee
4. College of Arts and Sciences Web site Committee
5. Contributor, NSF STEP Grant-Texas Southern University College of Science and Technology Enhancement Program

Past: 

1. College of Arts and Sciences Hearing and Grievance Committee
2. College of Arts and Sciences Representative to the University "Placement Center" Committee
3. College of Arts and Sciences Representative to the University Research Council
4. Academic Support Committee to advise Information Technology Governance Committee
5. Evaluation Committee for review of Faculty Performance and Post-Tenure Review Instrument
6. Department of Biology Grievance Committee
1. Committee Member, Joint Admission Medical Program for Pre-Medical Students (JAMP)
• Co-Director, Texas Southern University / University of  Texas Medical Branch Early Medical School Acceptance Program (EMSAP)
• Harris County 4-H College Day, Recruitment for TSU/ UTMB Early Medical School Acceptance Program
• Panel Committee Member, Consensus Development Conference on Screening and Management for Phenylketonuria (PKU) 1999-2001
• Mentor, Alejandra Serna, Biology Student, Pearland High School 
• Speaker, The Career Seminar Series, Baylor College of Medicine, Department of Molecular Physiology and Biophysics,  “Undergraduate Teaching” April 4, 2001
• HISD Teachers Educational and Cultural Tour to Taiwan March 10-17, 2001
• Instructor, College of Continuing Education Project GRAD
• Speaker, Career Day, 8th Avenue Elementary, HISD

Jejelowo, O.A. -  Professor

List Research Interest Keywords:

Fungi, Plants, Air Quality, Phytoalexins, Antibiotic Resistance, Plant Pathology, Biotechnology, Nanotechnology

Review Panels:

National Science  Foundation - Oak Ridge Universities NASA

Training/Instructional Capability:

• Biology, Botany, Microbiology, Biotechnology, Plant Pathology

Selected Publications:

1. Jejelowo, O.A. (2000)  Mold development in hydroponically grown wheat (Current Microbiology, In Press)
2. Jejelowo, O.A. (2000)  Mold management – Inspection 2000; NASA JSC
3. Jejelowo, O.A. & S.P. Abraham  (1998) Texas J. Sci. 50 (2) 143 - 148
4. Jejelowo, O.A. et  al (1995) Phytopathology  85 (10) 1202
5. Jejelowo, O.A. et  al (1988) Trans. Boi. Mycol. Soc. 91-653-660
6. Jejelowo, O.A. et  al (1988) Trans. Boi. Mycol. Soc. 91-661-669

Externally Funded Projects: (Title of Project and Funding Agency)

1. Mold Development in Hydroponically grown graniumaceous crop plant    $60,000 = funded. NASA (2000-2001)
2. Silicon uptake in hydroponically grown graniumaceous crop plants $62,000 =     funded. NASA. (2000 – 2001) 

Recent Proposals Written:

• Mold development in hydroponically grown crop plants. NASA. Amount requested ($175,000 ; 2000 – 2003) Addition.

Recent Professional Conferences Attended:

• Texas Academy of Sciences Annual Meeting American Phytopathological Society AGM Inspection 2000. NASA JSC

Recent Training Workshops Attended: (TSU or External)

• NASA Administrator’s Professional development Institutes. Institutes II Albuquerque, N.M.
• Institute III Dec. 3-4-2000, Hampton, VA

List of Professional Activities:

• Actively involved as past section chair and board member (academic director) of the Texas Academy of Sciences.
• Member of Space Committee, American Phytopathological Society.

List of Community and University Services:

• Research Day Committee
• Faculty Development Committee
• Science Fair Judge Fondren Middle Schl.
• Faculty Sponsor/Member Tri-beta club
• Active in developing proposals for the Environmental Institute

Shishodia, Shishir - Assistant Professor 

 List Research Interest Keywords:

NF-kB is an inducible and ubiquitously expressed transcription factor for genes involved in cell survival, cell adhesion, inflammation, differentiation and growth.

Review Panels:

Training/Instructional Capability:

Selected Publications:

1.        Shishodia S and Aggarwal BB (2005) Diosgenin Inhibits Osteoclastogenesis, Invasion, And Proliferation Through The Downregulation of Akt, IkB Kinase Activation And NF-kB-Regulated Gene Expression. Oncogene (in press)

2.        Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, and Aggarwal BB (2005) Curcumin (Diferuloylmethane) Downregulates Expression of Cell Proliferation, Antiapoptotic and Metastatic Gene Products Through Suppression of IkBa Kinase and AKT Activation. Molecular Pharmacology, Oct 2005 (epub ahead of print).        

3.        Shishodia S, Gutierrez AM, Lotan R, and Aggarwal BB. (2005) Inhibition of IkBa kinase by N-(4-hydroxyphenyl) retinamide downregulates NF-kB-regulated angiogenic and antiapoptotic gene products; and enhances apoptosis. Cancer Research, 65:9555-65.

4.          Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman R, Bueso-Ramos CE, and Price JE (2005) Curcumin  Suppresses the Paclitaxel-induced NF-kB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of  Human Breast Cancer in Nude Mice. Cinical Cancer Research, 11(20):7490-8.

5.         Shishodia S, Amin HM, Lai R, and Aggarwal BB. (2005) Curcumin (Diferuloylmethane) Inhibits Constitutive NF-kB Activation, Induces G1/S Arrest, Suppresses Proliferation and Induces Apoptosis in Mantle Cell Lymphoma. Biochemical Pharmacology. 70:700-713.

6.         Siwak DR, Shishodia S, Aggarwal BB, and Kurzrock R (2005) Curcumin-induced antiproliferative and proapoptotic effect in melanoma cells is associated with suppression of IKK and NF-kB activity, and is independent of the B-Raf/MEK/ERK and Akt pathways. Cancer. 104:879-890.

7.         Amit-Vazina M, Shishodia S, Harris D, Van Q, Weber D, Alexanian R, Talpaz M, Aggarwal BB and Estrov Z. (2005) Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells. British Journal of Cancer. 93:70-80.

8.         Shishodia S, Takada Y, and Aggarwal BB. (2005) Therapeutic Implications of Gene Deletion of Ligands and Receptors of Members of TNF Superfamily. Medicinal Chemistry Reviews – Online. 2(2):163-175.

9.         Aggarwal BB and Shishodia S.  (2004) Suppression of Nuclear Factor-kB activation pathway by spice-derived phytochemicals:reasoning for seasoning. Annals of the New York Academy of Sciences. 1030: 434-441. 

10.       Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, and Takada Y (2004) Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies. Anticancer Research. 24(5A):2783-840. 

11.       Li L, Aggarwal BB, Shishodia S, Abbruzzese J, and Kurzrock R. (2004). Nuclear Factor-kB and IkB Kinase are Constitutively Active in Human Pancreatic Cells and their Down-regulation by Curcumin (diferuloyl methane) is Associated with Suppression of Proliferation and Induction of Apoptosis. Cancer. 101(10): 2351-62..

12.      Shishodia S, and Aggarwal BB. (2004) Guggulsterone Inhibits NF-kB and IkBa Kinase Activation, Suppresses Expression of Antiapoptotic Gene Products and Enhances Apoptosis. Journal of Biological Chemistry. 279(45): 47148-47158. 

13.      Shishodia S, and Aggarwal BB. (2004). Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates Cigarette Smoke-Induced NF-kB Activation Through Inhibition of Activation of IkBa Kinase Human Non-small Cell Lung Carcinoma: Correlation with Suppression of Cyclin D1, COX-2, and Matrix Metalloproteinase-9. Cancer Research 64: 5004-5012.

14.      Shishodia S, Koul D and Aggarwal BB. (2004)) Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates Tumor Necrosis Factor-Induced NF-kB Activation Through Inhibition of Activation of IkBa Kinase and Akt in Human Non-small Cell Lung Carcinoma:Correlation with suppression of COX2 synthesis Journal of  Immunology. 173(3):2011-22.

15.      Shishodia S, and Aggarwal BB (2004) Nuclear Factor-kB: A Friend or a Foe in Cancer? Biochemical Pharmacology. 68(6), 1071-1080.

16.      Shishodia S, and Aggarwal BB. (2004) Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat. Res.119:139-73. 

17.      Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, and Aggarwal BB. (2004)  Nuclear Factor-kB and STAT3 are Constitutively Active in CD138+ Cells Derived from Multiple Myeloma Patients and Their Suppression Leads to Apoptosis. Blood 103(8): 3175-3184. 

18.      Bueso-Ramos CE, Rocha FC, Shishodia S, Kantarjian HM, Medeiros LJ, Vadhan-Raj S, Estrov Z, Smith TL, Nguyen MH, and Aggarwal BB. (2004) High Expression of Constitutively Active Nuclear-kB relA Transcription Factor is Present in Blasts of Acute Myeloid Leukemia. Human Pathology, 35(2): 246-53 

19.      Bharti AC, Takada Y, Shishodia S, and Aggarwal BB. (2004) Evidence that RANK Ligand can suppress cell proliferation and induce apoptosis through activation of a Nuclear Factor-kB-independent and TRAF6-dependent mechanism. Journal of Biological Chemistry. 279, 6065-6076. 

20.      Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB, Shishodia S, Albitar M, Hayes K, Kantarjian H, and Talpaz M. (2004) Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia. Cancer Research, 64(2): 672-7. 

21.       Ashikawa K, Shishodia S, Fokt I, Priebe W, and Aggarwal BB. (2004) Evidence That Activation of Nuclear Factor-kB Is Essential for Doxorubicin-Induced Cell Death in Myeloid and Lymphoid Cells. Biochemical Pharmacology, 67, 353-364. 

22.       Aggarwal BB, Takada Y, Shishodia S, Gutierrez AM, Oommen OV, Ichikawa H, Baba Y, and Kumar A. (2004) Nuclear transcription Factor NF-kB: Role in Biology and Medicine. Indian Journal of Experimental Biology. 42, 341-353. 

23.      Thompson MP, Aggarwal BB, Shishodia S, Estrov Z, and Kurzrock R. (2003) Autocrine lymphotoxin production in Epstein-Barr Virus (EBV)-immortalized B-cells: induction via NF-kB activation mediated by EBV-derived Latent Membrane Protein 1. Leukemia, 17:2196-2201.

24.      Shishodia S, Majumdar S  and Aggarwal BB. (2003) Ursolic Acid Inhibits Nuclear Factor-kB Activation Induced by Carcinogenic Agents Through Suppression of IkBa Kinase and p65 Phosphorylation: Correlation with Downregulation of COX2, MMP-9 and CyclinD1. Cancer Research 63, 4375-4383.

25.      Shishodia S, Potdar P, Gairola GC and Aggarwal BB (2003) Curcumin downregulates cigarette smoke condensate-induced NF-kappa B activation through inhibition of IkBa kinase in human lung cancer cells: correlation with suppression of COX2 and MMP-9. Carcinogenesis 24(7), 1269-1279. 

26.       Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M. and Aggarwal BB (2003) Resveratrol blocks interleukin-1b-induced activation of the nuclear transcription factor NF-kB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 102(3), 987-995. 

27.      Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S and Aggarwal BB. (2002). Trans-3,4,3’,5’-tetrahydroxystilbene (piceatannol) inhibits TNF-induced nuclear Factor-appaB activation through suppression of IkBakinase and p65 phosphorylation. Journal of Immunology.169 (11) 6490-6497. 

28.      Anto RJ, Mukhopadhyay A, Shishodia S, Gairola CG, and Aggarwal BB. (2002) Cigarette smoke condensate activates nuclear transcription factor-kappa B through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis.23(9):1511-1518. 

29.      Mukhopadhyay A, Shishodia S, Suttles J, Brittingham K, Lamothe B, Nimmanapalli R, Bhalla KN, Aggarwal BB. (2002) Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors. Journal of Biological Chemistry. 277(34):30622-30628. 

30.       Mukhopadhyay A, Shishodia S, Fu XY, Aggarwal BB. (2002) Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha. Journal of Cellular Biochemistry. 84(4): 803-815. 

31.      Aggarwal BB, Shishodia S, Ashikawa K, and Bharti AC. (2002). The Role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Current Drug Targets: Inflammation and Allergy, 1:327-341. 

32.       Shishodia S, and Aggarwal BB. (2002) Nuclear factor-kappa B activation: A question of life and death. Journal of Biochemistry Molecular Biology. 35: 28-40. 

33.      Shrivastava A, Shishodia S, and Sodhi A. (1998) Expression of LFA-1 adhesion molecules on cisplatin treated macrophages. Biochimica et Biophysica Acta. 1402(3): 269-276. 

34.      Shishodia S, Shrivastava A, and Sodhi A. (1998) Involvement of Ras and MAP kinase (ERK-1) in cisplatin-induced activation of bone marrow derived macrophages. Biochemistry and Molecular Biology International. 45(3): 527-534. 

35.       Shishodia S, Shrivastava A, and Sodhi A. (1998) Protein Kinase C: a potential pathway of macrophage activation with cisplatin. Immunology Letters. 61:179-186. 

36.       Shishodia S, Sodhi A, and Shrivastava A. (1998) Cisplatin stimulated murine bone marrow derived macrophages require Ca ions. Journal of Clinical Biochemistry and Nutrition. 24:1-12. 

37.       Shishodia S, Shrivastava A, and Sodhi A. (1997) Cisplatin stimulated murine bone marrow-derived macrophages require protein tyrosine phosphorylation. International Journal of Immunopharmacology. 19: 683-690.

38.       Sodhi A, Shishodia S, and Shrivastava A. (1997) Cisplatin - stimulated murine bone marrow-derived macrophages secrete oncostatin M. Immunology and Cell Biology. 75: 492-496.

39.      Shrivastava A, Shishodia S, and Sodhi A. (1997) Activation of murine peritoneal macrophages and macrophage cell lines P388D-1 and IC-21 with cisplatin. International Journal of Immunopathology and Immunopharmacology. 10: 13-21.

 Invited lectures:

03/25/2003: NF-kB as a Target for Cigarette Smoke-Induced Carcinogenesis of the Lung and Head and Neck Cancers, Bioimmunotherapy Lecture Series, Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

11/25/2003: Identification of Novel Triterpenoids as Suppressor of Transcription Factor: Potential Role in Chemoprevention. Bioimmunotherapy Lecture Series, Department of Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

01/16/2004: Targeting Transcriptional Factors by Plant Polyphenols: Role in Prevention and Therapy of Cancer, Institutional Grand Rounds, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030. 

11/14/2004: Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. Third International Conference on Mechanisms of Action of Nutraceuticals, November 12-14, 2004, Haywood County, North Carolina.

06/17/2005: Mechanism of cigarette smoke-induced carcinogenesis and its suppression, Odyssey Mini Symposium, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

11/10/2005: Curcumin: The Indian Solid Gold, Supply Side West Show, (Sabinsa Corporation), The Venetian, Las Vegas, NV.

Recent Proposals Written:

Recent Professional Conferences Attended:

Recent Training Workshops Attended:

List of Professional Activities:

List of Community and University Services:

Awards and Special Recognitions:

• BHU Medal for highest grades in M.S. (Zoology) program, Banaras Hindu University
• Ramkrishna Reddy Award for highest grade in Biochemistry special paper in the M. S. (Zoology) program, Banaras Hindu University, Varanasi, India
• AB Mishra Memorial Endowment Award, first in the order of merit in the M.S. (Zoology) program, Banaras Hindu University, Varanasi, India
•  Book Award from Jawaharlal Nehru Memorial Fund for Academic Distinction in M.S. (Zoology) program at Banaras Hindu University,Varanasi, India
• Junior Research Fellowship award, Council of Scientific and Industrial Research, New
• Delhi, India.Senior Research Fellowship award, Council of Scientific and Industrial Research, New Delhi, India.
• The University of Texas M.D. Anderson Cancer Center Odyssey Special Fellow Award sponsored by the Theodore N. Law Award for Scientific Achievement. The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

Williams, Warren E. - Associate Professor

List Research Interest Keywords:

Viral Genetic (Bacteriophage)

Review Panels:

• NSF

Training/Instructional Capability:

• Cellular Biology
• Molecular Genetics
• Endocrinology

Selected Publications:

1. Williams, W.E. & J.W. Wrake. Mutagenesis in Bacteriophage T4. American Society fun Microbiology 104:218
2. Cormien, Ethel M. & Warren E. Williams Ethyl Methane Sulfurate Induced Revision During Cytosine Deprivation in Bacteriophage. I Inactivation Kinetics, Mutation Research.
3. Williams, Warren and John W. Winke. Mutator Mutations in Bacteriophage, T4  Gene 42

Recent Proposals Written:

Recent Professional Conferences Attended:

Recent Training Workshops Attended: (TSU or External)

List of Professional Activities:

• Sigma X
• New York Academy of Sciences
• Beta Kappa Chi National Scientific Honor Society
• American Society for Microbiology
• American Association for the Advancement of Science 

List of Community and University Services:

• Program Director – Minority Biomedical Research Support Grant (1986-1992)
• Chair – Dept. of Biology  (1986-1992)
• Chair – Committee for the Protection of Human Research Subjects (1986-present)
• Member – College of Arts and Sciences Assessment Committee
• Member – College of Arts and Sciences Grievances Committee
• Member – Institutional Surveillance Committee; M.W. Anderson Hospital and Turner Institute. (1979-1986)

Awards and Special Recognitions: